PREVALENCE AND DETERMINANTS OF FEMALE SEXUAL DYSFUNCTION AMONG TYPE 2 PATIENTS OF DIABETES IN HYDERABAD, PAKISTAN: A CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.63075/fy7cx730Keywords:
Female sexual dysfunction; Type 2 diabetes mellitus; Education; Prevalence; Determinants; PakistanAbstract
The purpose of this study was to identify the prevalence and associated risk factors of female sexual dysfunction (FSD) in women with Type 2 diabetes mellitus (T2DM) in Hyderabad, Pakistan. This cross-sectional analytical survey was conducted among 170 married women who were registered in outpatient clinics for T2DM at a hospital in Hyderabad. A standardized questionnaire was used as the primary means of collecting demographic and clinical information about each participant, as well as using the FSFI test to screen for sexual dysfunction; the Patient Health Questionnaire (PHQ) to assess depressive symptoms; and recent HbA1c levels to determine glycemic control. Multiple logistic regression analyses were conducted to examine the association between participant characteristics and sexual dysfunction. The overall prevalence of FSD among the study population was 62.9%. The FSFI domain with the most dysfunction was sexual desire (69.2%), followed by arousal (64.5%); the least dysfunctional domain was pain (38.3%). Significant predictors of FSD identified by multivariable analysis were: age of ≥40 years (AOR = 1.97; 95% CI, 1.10-3.54), diabetes duration of ≥5 years (AOR = 1.76; 95% CI, 1.01–3.08), glycemic control of (HbA1c ≥7.0%) (AOR = 2.21; 95% CI, 1.25-3.92), diabetic complications (AOR = 1.88; 95% CI, 1.05–3.36) and depressive symptoms (AOR = 2.67; 95% CI = 1.42-5.01). Additionally, women who had completed secondary education or higher were less likely to have FSD (AOR = 0.58; 95% CI, 0.33-0.99).Downloads
Published
2026-02-28
Issue
Section
Articles
How to Cite
PREVALENCE AND DETERMINANTS OF FEMALE SEXUAL DYSFUNCTION AMONG TYPE 2 PATIENTS OF DIABETES IN HYDERABAD, PAKISTAN: A CROSS-SECTIONAL STUDY. (2026). Review Journal of Neurological & Medical Sciences Review, 4(2), 392-402. https://doi.org/10.63075/fy7cx730